{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:35:48Z","timestamp":1792884948306,"version":"4.5.0"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cairo University","id":[{"id":"https:\/\/ror.org\/03q21mh05","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tanshinones, a class of lipophilic abietane-type diterpenoid, represents the major bioactive constituents of\n                    <jats:italic>Salvia miltiorrhiza<\/jats:italic>\n                    Bunge (Danshen), a key herb in traditional Chinese medicine with growing therapeutic importance. This review offers an in-depth overview of tanshinones from phytochemical and pharmacological perspectives. The review outlines the biosynthetic pathway, highlights the key synthetic approaches, and provides a detailed chemical and stereochemical characterization of the major tanshinones isomers. Pharmacologically, tanshinones exhibit broad, multi-system activities including antioxidant and anti-inflammatory effects, cardiovascular and hepatorenal protection, antitumor activity, immunomodulatory effects, and therapeutic benefits across neurological, metabolic, skeletal, respiratory, and infectious diseases. Despite their broad therapeutic potential, progression of tanshinones toward clinical application is restricted by low oral bioavailability, poor aqueous solubility, and rapid metabolism. To overcome these barriers, novel drug-delivery strategies including lipid nanocapsules, liposomes, polymeric nanoparticles, solid liquid nanoparticles, microemulsions, and nanoemulsions significantly improve solubility, stability, and pharmacokinetics. This review integrates the current evidence to guide future optimization and mechanistic exploration and support the development of innovative nanoformulations for next-generation tanshinone-based therapies.\n                  <\/jats:p>","DOI":"10.1007\/s00210-026-05664-4","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T03:05:01Z","timestamp":1784516701000},"page":"20215-20260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling potent therapeutic potentials of tanshinones, lipophilic abietane diterpenes: a holistic literature review"],"prefix":"10.1007","volume":"399","author":[{"given":"Shymaa I. A.","family":"Abdel-dayem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania M.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba R.","family":"Ghaiad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam K.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya H.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El-Dessouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Elazazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Saeed","family":"EL-Tokhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally A.","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3179-3352","authenticated-orcid":false,"given":"Riham A.","family":"El-Shiekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M. Abd","family":"Elghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"5664_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1638629","volume":"16","author":"Z An","year":"2025","unstructured":"An Z, Wu B, Mao W, Wu L (2025) Mechanisms and traditional Chinese medicine therapeutics for primary osteoporosis: an integrated perspective. Front Endocrinol 16:1638629","journal-title":"Front Endocrinol"},{"issue":"2","key":"5664_CR2","doi-asserted-by":"publisher","DOI":"10.2174\/0115734137354461250312091944","volume":"22","author":"I Arif","year":"2026","unstructured":"Arif I et al (2026) Nanoparticles for the delivery of drugs to specific targets: an update. Curr Nanosci 22(2):e15734137354461","journal-title":"Curr Nanosci"},{"key":"5664_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.103178","volume":"98","author":"S Ashique","year":"2026","unstructured":"Ashique S et al (2026) Exosome as emerging therapeutic platform for wound healing: current status, advancement and future crosstalk. Tissue Cell 98:103178","journal-title":"Tissue Cell"},{"key":"5664_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119598","volume":"586","author":"AA Ashour","year":"2020","unstructured":"Ashour AA, Ramadan AA, Abdelmonsif DA, El-Kamel AH (2020) Enhanced oral bioavailability of tanshinone IIA using lipid nanocapsules: formulation, in-vitro appraisal and pharmacokinetics. Int J Pharm 586:119598","journal-title":"Int J Pharm"},{"key":"5664_CR5","doi-asserted-by":"crossref","unstructured":"Ashour AA, El-Kamel AH, Abdelmonsif DA, Khalifa HM, Ramadan AA (2021) Modified lipid nanocapsules for targeted tanshinone IIA delivery in liver fibrosis. Int J Nanomed 8013\u20138033","DOI":"10.2147\/IJN.S331690"},{"key":"5664_CR6","doi-asserted-by":"publisher","unstructured":"Azzam HN, El-Dessouki AM, Attallah KA, Sadek MA, Aboulmagd YM, Hassan M-AM, Fahmy MI, El-Shiekh RA, Kamal RM and Khalifa HO (2025) Morusin as a drug candidate: opportunities, limitations, and the path toward clinical translation. Front Pharmacol 16:1704535. https:\/\/doi.org\/10.3389\/fphar.2025.1704535","DOI":"10.3389\/fphar.2025.1704535"},{"key":"5664_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2433710","volume":"46","author":"Y Bai","year":"2024","unstructured":"Bai Y et al (2024) Tanshinone I improves renal fibrosis by promoting gluconeogenesis through upregulation of peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1. Ren Fail 46:2433710","journal-title":"Ren Fail"},{"key":"5664_CR8","doi-asserted-by":"crossref","unstructured":"Baillie A, Thomson R (1968) Naturally occurring quinones. Part XI. The tanshinones. J Chem Soc C: Organic 48\u201352","DOI":"10.1039\/j39680000048"},{"key":"5664_CR9","doi-asserted-by":"crossref","unstructured":"Cai Y, Zhang W, Chen Z, Shi Z, He C, Chen M (2016) Recent insights into the biological activities and drug delivery systems of tanshinones. Int J Nanomed 121\u2013130","DOI":"10.2147\/IJN.S84035"},{"key":"5664_CR10","doi-asserted-by":"crossref","unstructured":"Cai C et al. (2025) The nanocrystal-loaded liposome of tanshinone IIA with high drug loading and stability towards efficient liver fibrosis reversion. Nanomed: Nanotechnol, Biol Med 63:102797","DOI":"10.1016\/j.nano.2024.102797"},{"key":"5664_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biom13071029","volume":"13","author":"S Carpi","year":"2023","unstructured":"Carpi S et al (2023a) Tanshinone IIA and cryptotanshinone counteract inflammation by regulating gene and miRNA expression in human SGBS adipocytes. Biomolecules 13:1029","journal-title":"Biomolecules"},{"key":"5664_CR12","doi-asserted-by":"crossref","unstructured":"Carpi S et al. (2023b) Tanshinone IIA and cryptotanshinone counteract inflammation by regulating Gene and miRNA expression in human SGBS adipocytes 13:1029","DOI":"10.3390\/biom13071029"},{"key":"5664_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/450572","volume":"2014","author":"J-D Cha","year":"2014","unstructured":"Cha J-D, Lee J-H, Choi KM, Choi S-M, Park JH (2014) Synergistic effect between cryptotanshinone and antibiotics against clinic methicillin and vancomycin-resistant Staphylococcus aureus. Evidence-Based Complement Altern Med 2014:450572","journal-title":"Evidence-Based Complement Altern Med"},{"key":"5664_CR14","doi-asserted-by":"crossref","unstructured":"Chen P et al (2025) Therapeutic potential of tanshinone IIA in folic acid-induced acute kidney injury: a network pharmacology approach. Biotech Histochem 101(2):69\u201383","DOI":"10.1080\/10520295.2025.2589264"},{"key":"5664_CR15","doi-asserted-by":"publisher","first-page":"31915","DOI":"10.18632\/oncotarget.16651","volume":"8","author":"X Chen","year":"2017","unstructured":"Chen X et al (2017) Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation. Oncotarget 8:31915\u201331922","journal-title":"Oncotarget"},{"key":"5664_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.647289","volume":"12","author":"B-C Chen","year":"2021","unstructured":"Chen B-C et al (2021a) New insights into the antibacterial mechanism of cryptotanshinone, a representative diterpenoid quinone from Salvia miltiorrhiza Bunge. Front Microbiol 12:647289","journal-title":"Front Microbiol"},{"key":"5664_CR17","first-page":"4788","volume":"13","author":"L Chen","year":"2021","unstructured":"Chen L, Wu J, Xu H, Chen J, Xie X (2021b) Effects of tanshinone combined with valsartan on hypertensive nephropathy and its influence on renal function and vascular endothelial function. Am J Transl Res 13:4788","journal-title":"Am J Transl Res"},{"key":"5664_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3892\/mmr.2021.12043","volume":"23","author":"R Chen","year":"2021","unstructured":"Chen R, Chen W, Huang X, Rui Q (2021c) Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats. Mol Med Rep 23:404","journal-title":"Mol Med Rep"},{"key":"5664_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041990","volume":"28","author":"Z Chen","year":"2023","unstructured":"Chen Z et al (2023) Renoprotective effects of tanshinone IIA: a literature review. Molecules 28:1990","journal-title":"Molecules"},{"key":"5664_CR20","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1021\/acsbiomaterials.4c00532","volume":"10","author":"W Chen","year":"2024","unstructured":"Chen W et al (2024) Tanshinone IIA loaded inhaled polymer nanoparticles alleviate established pulmonary fibrosis. ACS Biomater Sci Eng 10:6250\u20136262","journal-title":"ACS Biomater Sci Eng"},{"key":"5664_CR21","first-page":"1457","volume":"10","author":"L Cheng","year":"2018","unstructured":"Cheng L et al (2018) Tanshinone IIA attenuates osteoclastogenesis in ovariectomized mice by inactivating NF-kB and Akt signaling pathways. Am J Transl Res 10:1457","journal-title":"Am J Transl Res"},{"key":"5664_CR22","first-page":"3140","volume":"11","author":"W Cheng","year":"2019","unstructured":"Cheng W, Xiang W, Wang S, Xu K (2019) Tanshinone IIA ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection and autophagy promotion. Am J Transl Res 11:3140\u20133149","journal-title":"Am J Transl Res"},{"key":"5664_CR23","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.3892\/mmr.2017.6359","volume":"15","author":"TL Chiu","year":"2017","unstructured":"Chiu TL, Su CC (2017) Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1\u03b1, CHOP, caspase-3 and caspase-12 in pancreatic cancer BxPC-3 cell-derived xenograft tumors. Mol Med Rep 15:3259\u20133263","journal-title":"Mol Med Rep"},{"key":"5664_CR24","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1038\/s41598-019-42164-3","volume":"9","author":"A Contreras","year":"2019","unstructured":"Contreras A, Leroy B, Mariage P-A, Wattiez R (2019) Proteomic analysis reveals novel insights into tanshinones biosynthesis in Salvia miltiorrhiza hairy roots. Sci Rep 9:5768","journal-title":"Sci Rep"},{"key":"5664_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/molecules23030623","volume":"23","author":"J Dang","year":"2018","unstructured":"Dang J et al (2018) Efficient separation of four antibacterial diterpenes from the roots of Salvia prattii using non-aqueous hydrophilic solid-phase extraction followed by preparative high-performance liquid chromatography. Molecules 23:623","journal-title":"Molecules"},{"key":"5664_CR26","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.biopha.2018.06.047","volume":"105","author":"L Di Cesare Mannelli","year":"2018","unstructured":"Di Cesare Mannelli L et al (2018) Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy. Biomed Pharmacother 105:1042\u20131049","journal-title":"Biomed Pharmacother"},{"key":"5664_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12974-020-01981-4","volume":"17","author":"B Ding","year":"2020","unstructured":"Ding B et al (2020) Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE\/NF-\u03baB signaling pathway in vivo and in vitro. J Neuroinflammation 17:302","journal-title":"J Neuroinflammation"},{"key":"5664_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.70099","author":"F Ding","year":"2025","unstructured":"Ding F et al (2025a) Sodium tanshinone IIA sulfonate ameliorates fibrosis of skeletal muscle injury by regulating transforming growth factor\u2010\u03b21\/Smad3 and phosphoinositide 3\u2010kinase\/protein kinase B\/cyclooxygenase\u20102 signaling pathways. Cell Biol Int. https:\/\/doi.org\/10.1002\/cbin.70099","journal-title":"Cell Biol Int"},{"key":"5664_CR29","doi-asserted-by":"publisher","unstructured":"Ding Z et al (2025b) Progress of tanshinone IIA against respiratory diseases: therapeutic targets and potential mechanisms. Front Pharmacol 16:1505672. https:\/\/doi.org\/10.3389\/fphar.2025.1505672","DOI":"10.3389\/fphar.2025.1505672"},{"key":"5664_CR30","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1021\/acs.molpharmaceut.4c00042","volume":"21","author":"T Dong","year":"2024","unstructured":"Dong T et al (2024) Tanshinone IIA liposomes treat doxorubicin-induced glomerulonephritis by modulating the microenvironment of fibrotic kidneys. Mol Pharm 21:3281\u20133295","journal-title":"Mol Pharm"},{"key":"5664_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.860383","volume":"13","author":"J-Y Dou","year":"2022","unstructured":"Dou J-Y et al (2022) Salvia miltiorrhiza Bunge (Danshen) and bioactive compound tanshinone IIA alleviates cisplatin-induced acute kidney injury through regulating PXR\/NF-\u03baB signaling. Front Pharmacol 13:860383","journal-title":"Front Pharmacol"},{"key":"5664_CR32","doi-asserted-by":"publisher","unstructured":"El-Dessouki AM, Attallah KA, Eid AH, Zaki ES, Khalaf SS, El-Shiekh RA, Kamel NM, ElBishbishy RM, Elosaily AH (2026) Viniferin and its derivatives: a comprehensive review of structural variations and promising pharmacological applications in disease prevention and therapeutic development. Naunyn Schmiedebergs Arch Pharmacol 399(5):6189\u20136220. https:\/\/doi.org\/10.1007\/s00210-025-04678-8","DOI":"10.1007\/s00210-025-04678-8"},{"key":"5664_CR33","doi-asserted-by":"publisher","first-page":"29267","DOI":"10.1039\/D1RA05268C","volume":"11","author":"D Elebeedy","year":"2021","unstructured":"Elebeedy D et al (2021) Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights. RSC Adv 11:29267\u201329286","journal-title":"RSC Adv"},{"key":"5664_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.105149","volume":"141","author":"D Elebeedy","year":"2022","unstructured":"Elebeedy D et al (2022) In vitro and computational insights revealing the potential inhibitory effect of tanshinone IIA against influenza A virus. Comput Biol Med 141:105149","journal-title":"Comput Biol Med"},{"key":"5664_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111348","volume":"122","author":"Y Fan","year":"2024","unstructured":"Fan Y, Kang S, Shao T, Xu L, Chen J (2024) Activation of SIRT3 by tanshinone IIA ameliorates renal fibrosis by suppressing the TGF-\u03b2\/TSP-1 pathway and attenuating oxidative stress. Cell Signal 122:111348","journal-title":"Cell Signal"},{"key":"5664_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.611087","volume":"11","author":"Z Fang","year":"2021","unstructured":"Fang Z et al (2021) Tanshinone IIA: a review of its anticancer effects. Front Pharmacol 11:611087","journal-title":"Front Pharmacol"},{"key":"5664_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112314","volume":"378","author":"SF Fawzi","year":"2020","unstructured":"Fawzi SF, Menze ET, Tadros MG (2020) Deferiprone ameliorates memory impairment in scopolamine-treated rats: the impact of its iron-chelating effect on \u03b2-amyloid disposition. Behav Brain Res 378:112314","journal-title":"Behav Brain Res"},{"key":"5664_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cherd.2022.02.021","volume":"180","author":"I Fikri","year":"2022","unstructured":"Fikri I et al (2022) Optimization of supercritical fluid extraction of dihydrotanshinone, cryptotanshinone, tanshinone I, and tanshinone IIA from Salvia miltiorrhiza with a peanut oil modifier. Chem Eng Res des 180:220\u2013231","journal-title":"Chem Eng Res des"},{"key":"5664_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.816419","author":"Q Fu","year":"2022","unstructured":"Fu Q et al (2022) Tanshinone capsules combined with prednisone for facial seborrheic dermatitis: a systematic review and meta-analysis of randomized clinical trials. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.816419","journal-title":"Front Med"},{"key":"5664_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13577","volume":"30","author":"L Fu","year":"2024","unstructured":"Fu L et al (2024) Tanshinone IIA, a component of the self-made Xiao-Yin decoction, ameliorates psoriasis by inhibiting IL-17\/IL-23 and PTGS2\/NF-\u03baB\/AP-1 pathways. Skin Res Technol 30:e13577","journal-title":"Skin Res Technol"},{"key":"5664_CR41","volume":"14","author":"MS Gatto","year":"2024","unstructured":"Gatto MS, Johnson MP, Najahi-Missaoui W (2024) Targeted liposomal drug delivery: overview of the current applications and challenges. Life (Basel) 14:672","journal-title":"Life (Basel)"},{"key":"5664_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40709-019-0102-1","volume":"26","author":"L Geng","year":"2019","unstructured":"Geng L, Liu W, Chen Y (2019) Tanshinone IIA attenuates A\u03b2-induced neurotoxicity by down-regulating COX-2 expression and PGE2 synthesis via inactivation of NF-\u03baB pathway in SH-SY5Y cells. J Biol Res-Thessaloniki 26:15","journal-title":"J Biol Res-Thessaloniki"},{"key":"5664_CR43","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00262-019-02338-4","volume":"68","author":"Z Han","year":"2019","unstructured":"Han Z et al (2019) Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses. Cancer Immunol Immunother 68:1073\u20131085","journal-title":"Cancer Immunol Immunother"},{"key":"5664_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110215","volume":"762","author":"D Han","year":"2024","unstructured":"Han D et al (2024) Tanshinone IIA alleviates inflammation-induced skeletal muscle atrophy by regulating mitochondrial dysfunction. Arch Biochem Biophys 762:110215","journal-title":"Arch Biochem Biophys"},{"key":"5664_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/nu14153031","author":"J Hao","year":"2022","unstructured":"Hao J et al (2022) The antidiabetic activities of neocryptotanshinone: screened by molecular docking and related to the modulation of PTP1B. Nutrients. https:\/\/doi.org\/10.3390\/nu14153031","journal-title":"Nutrients"},{"key":"5664_CR46","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v23i9.12","author":"J Hao","year":"2024","unstructured":"Hao J, Zhang P, Fan L, Jiang S (2024) Efficacy of combined use of octreotide and sodium tanshinone IIA sulfonate in patients with cirrhosis complicated with severe acute pancreatitis. Trop J Pharm Res. https:\/\/doi.org\/10.4314\/tjpr.v23i9.12","journal-title":"Trop J Pharm Res"},{"key":"5664_CR47","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s13346-023-01407-7","volume":"14","author":"DM Hassan","year":"2024","unstructured":"Hassan DM, El-Kamel AH, Allam EA, Bakr BA, Ashour AA (2024) Chitosan-coated nanostructured lipid carriers for effective brain delivery of tanshinone IIA in Parkinson\u2019s disease: interplay between nuclear factor-kappa \u03b2 and cathepsin B. Drug Deliv Transl Res 14:400\u2013417","journal-title":"Drug Deliv Transl Res"},{"key":"5664_CR48","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.3892\/mmr.2015.3333","volume":"11","author":"H He","year":"2015","unstructured":"He H et al (2015) Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats. Mol Med Rep 11:4190\u20134196","journal-title":"Mol Med Rep"},{"key":"5664_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.synbio.2016.05.002","volume":"1","author":"W He","year":"2016","unstructured":"He W et al (2016) Discovery of tanshinone derivatives with anti-MRSA activity via targeted bio-transformation. Synth Syst Biotechnol 1:187\u2013194","journal-title":"Synth Syst Biotechnol"},{"key":"5664_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00796-23","volume":"97","author":"X He","year":"2023","unstructured":"He X et al (2023) Identification of tanshinone I as cap-dependent endonuclease inhibitor with broad-spectrum antiviral effect. J Virol 97:e0079623","journal-title":"J Virol"},{"key":"5664_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijcard.2010.12.012","volume":"157","author":"HJ Hong","year":"2012","unstructured":"Hong HJ et al (2012) Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway. Int J Cardiol 157:174\u2013179","journal-title":"Int J Cardiol"},{"key":"5664_CR52","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/ijms18030620","volume":"18","author":"M Hong","year":"2017","unstructured":"Hong M et al (2017) A biomedical investigation of the hepatoprotective effect of Radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets. Int J Mol Sci 18:620","journal-title":"Int J Mol Sci"},{"key":"5664_CR53","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1208\/s12249-010-9410-3","volume":"11","author":"L Hu","year":"2010","unstructured":"Hu L, Xing Q, Meng J, Shang C (2010) Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles. AAPS PharmSciTech 11:582\u2013587","journal-title":"AAPS PharmSciTech"},{"key":"5664_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetlet.2020.152102","volume":"61","author":"H Huang","year":"2020","unstructured":"Huang H, Song C, Wang Z, Li M, Chang J (2020) Total synthesis of tanshinone IIA. Tetrahedron Lett 61:152102","journal-title":"Tetrahedron Lett"},{"key":"5664_CR55","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1246\/bcsj.42.3318","volume":"42","author":"Y Inouye","year":"1969","unstructured":"Inouye Y, Kakisawa H (1969) Total syntheses of tanshinone-I, tanshinone-II and cryptotanshinone. Bull Chem Soc Jpn 42:3318\u20133323","journal-title":"Bull Chem Soc Jpn"},{"key":"5664_CR56","doi-asserted-by":"crossref","unstructured":"Itoh K, Mimura J, Yamamoto JAY, Signaling R (2010) Discovery of the negative regulator of Nrf2, Keap1: a historical overview 13:1665\u20131678","DOI":"10.1089\/ars.2010.3222"},{"key":"5664_CR57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3892\/mmr.2014.2254","volume":"10","author":"P Jiang","year":"2014","unstructured":"Jiang P, Li C, Xiang Z, Jiao B (2014) Tanshinone IIA reduces the risk of Alzheimer\u2019s disease by inhibiting iNOS, MMP-2 and NF-\u03baBp65 transcription and translation in the temporal lobes of rat models of Alzheimer\u2019s disease. Mol Med Rep 10:689\u2013694","journal-title":"Mol Med Rep"},{"key":"5664_CR58","doi-asserted-by":"publisher","first-page":"36698","DOI":"10.1038\/srep36698","volume":"6","author":"C Jiang","year":"2016","unstructured":"Jiang C et al (2016) Rescue therapy with tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3\u03b2. Sci Rep 6:36698","journal-title":"Sci Rep"},{"key":"5664_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154439","volume":"106","author":"Q Jiang","year":"2022","unstructured":"Jiang Q et al (2022) Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway. Phytomedicine 106:154439","journal-title":"Phytomedicine"},{"key":"5664_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321121","volume":"20","author":"X Jiang","year":"2025","unstructured":"Jiang X et al (2025) Voluntarily wheel running protects doxorubicin-induced kidney injury by inhibiting oxidative stress through mitochondrial function. PLoS ONE 20:e0321121","journal-title":"PLoS ONE"},{"key":"5664_CR61","doi-asserted-by":"crossref","unstructured":"Jin J et al. (2019) Tanshinone IIA attenuates estradiol-induced polycystic ovarian syndrome in mice by ameliorating FSHR expression in the ovary 17:3501\u20133508","DOI":"10.3892\/etm.2019.7352"},{"key":"5664_CR62","doi-asserted-by":"crossref","unstructured":"Jin Z, Chenghao Y, Cheng PJFIP (2022) Anticancer effect of tanshinones on female breast cancer and gynecological cancer 12:824531","DOI":"10.3389\/fphar.2021.824531"},{"key":"5664_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120488","volume":"298","author":"DY Jung","year":"2022","unstructured":"Jung DY, Suh N, Jung MH (2022) Tanshinone 1 prevents high fat diet-induced obesity through activation of brown adipocytes and induction of browning in white adipocytes. Life Sci 298:120488","journal-title":"Life Sci"},{"key":"5664_CR64","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2147\/DDDT.S132488","volume":"11","author":"F Ke","year":"2017","unstructured":"Ke F et al (2017) Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2\/STAT3 and PI3K\/Akt\/NF\u03baB pathways in cholangiocarcinoma cells. Drug des Devel Ther 11:1753\u20131766","journal-title":"Drug des Devel Ther"},{"key":"5664_CR65","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbrc.2012.07.093","volume":"425","author":"WS Kim","year":"2012","unstructured":"Kim WS et al (2012) Cryptotanshinone and tanshinone IIA enhance IL-15-induced natural killer cell differentiation. Biochem Biophys Res Commun 425:340\u2013347","journal-title":"Biochem Biophys Res Commun"},{"key":"5664_CR66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2009.04.040","volume":"285","author":"WY Lee","year":"2009","unstructured":"Lee WY, Liu KW, Yeung JH (2009) Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells. Cancer Lett 285:46\u201357","journal-title":"Cancer Lett"},{"key":"5664_CR67","doi-asserted-by":"publisher","first-page":"109217","DOI":"10.18632\/oncotarget.22649","volume":"8","author":"HP Lee","year":"2017","unstructured":"Lee HP et al (2017) Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells in vitro and in vivo. Oncotarget 8:109217\u2013109227","journal-title":"Oncotarget"},{"key":"5664_CR68","doi-asserted-by":"crossref","unstructured":"Li J et al. (2020a) Cryptotanshinone attenuates allergic airway inflammation through negative regulation of NF-\u03baB and p38 MAPK 84:268\u2013278","DOI":"10.1080\/09168451.2019.1687280"},{"key":"5664_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/927658","author":"F-L Li","year":"2012","unstructured":"Li F-L et al (2012) Tanshinone IIA inhibits growth of keratinocytes through cell cycle arrest and apoptosis: underlying treatment mechanism of psoriasis. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2012\/927658","journal-title":"Evid Based Complement Alternat Med"},{"key":"5664_CR70","doi-asserted-by":"crossref","unstructured":"Li S et al. (2015) Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling 16:176\u2013184","DOI":"10.4161\/15384047.2014.962960"},{"key":"5664_CR71","first-page":"1369","volume":"70","author":"N Li","year":"2018","unstructured":"Li N, Yang L, Zhang B, Chen SJJOP (2018) Tanshinone IIA effects on ovarian cancer cell line. Pharmacology 70:1369\u20131377","journal-title":"Pharmacology"},{"key":"5664_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110599","volume":"130","author":"Z Li","year":"2020","unstructured":"Li Z, Zou J, Cao D, Ma X (2020b) Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases. Biomed Pharmacother 130:110599","journal-title":"Biomed Pharmacother"},{"key":"5664_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22620","volume":"35","author":"S Li","year":"2021","unstructured":"Li S et al (2021) Tanshinone II A improves the chemosensitivity of breast cancer cells to doxorubicin by inhibiting \u03b2-catenin nuclear translocation. J Biochem Mol Toxicol 35:e22620","journal-title":"J Biochem Mol Toxicol"},{"key":"5664_CR74","doi-asserted-by":"publisher","first-page":"12224","DOI":"10.1080\/21655979.2022.2074619","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Tanshinone IIA down-regulates-transforming growth factor beta 1 to relieve renal tubular epithelial cell inflammation and pyroptosis caused by high glucose. Bioengineered 13:12224\u201312236","journal-title":"Bioengineered"},{"key":"5664_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1071415","volume":"13","author":"H Li","year":"2023","unstructured":"Li H et al (2023) Tanshinone IIA and hepatocellular carcinoma: a potential therapeutic drug. Front Oncol 13:1071415","journal-title":"Front Oncol"},{"key":"5664_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23648","volume":"38","author":"Q Li","year":"2024","unstructured":"Li Q et al (2024) Tanshinone IIA regulates CCl4 induced liver fibrosis in C57BL\/6J mice via the PI3K\/Akt and Nrf2\/HO-1 signaling pathways. J Biochem Mol Toxicol 38:e23648","journal-title":"J Biochem Mol Toxicol"},{"key":"5664_CR77","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s13273-024-00487-x","volume":"21","author":"J Li","year":"2025","unstructured":"Li J, Jiang X, Chen X, Li ZJM (2025a) Dihydrotanshinone I ameliorated angiotensin II-induced mitochondrial damage and oxidative stress in vascular smooth muscle cells. Mol Cell Toxicol 21:833\u2013842","journal-title":"Mol Cell Toxicol"},{"key":"5664_CR78","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-025-01718-7","volume":"25","author":"Y Li","year":"2025","unstructured":"Li Y et al (2025b) Tanshinone IIA ameliorates pancreatic injury in type 2 diabetic mice by modulating inflammation and endoplasmic reticulum stress via the IL-6\/JAK2\/STAT3 pathway. Funct Integr Genomics 25:205","journal-title":"Funct Integr Genomics"},{"key":"5664_CR79","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1002\/ptr.6392","volume":"33","author":"XZ Liao","year":"2019","unstructured":"Liao XZ et al (2019) Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase\/Akt signalling pathway. Phytother Res 33:2298\u20132309","journal-title":"Phytother Res"},{"key":"5664_CR80","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1080\/13880209.2017.1401648","volume":"55","author":"C-Y Lin","year":"2017","unstructured":"Lin C-Y et al (2017) Antifatigue properties of tanshinone IIA in mice subjected to the forced swimming test. Pharm Biol 55:2264\u20132269","journal-title":"Pharm Biol"},{"key":"5664_CR81","doi-asserted-by":"crossref","unstructured":"Liu J et al. (2022) Salvia miltiorrhiza Bge. (Danshen) in the treating non-alcoholic fatty liver disease based on the regulator of metabolic targets. Front Cardiovasc Med 9:842980","DOI":"10.3389\/fcvm.2022.842980"},{"key":"5664_CR82","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jpba.2010.03.041","volume":"53","author":"Y Liu","year":"2010","unstructured":"Liu Y, Li X, Li Y, Wang L, Xue M (2010) Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatographic\u2013mass spectrometry and the application to pharmacokinetics in rats. J Pharm Biomed Anal 53:698\u2013704","journal-title":"J Pharm Biomed Anal"},{"key":"5664_CR83","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.seppur.2013.03.012","volume":"110","author":"F Liu","year":"2013","unstructured":"Liu F et al (2013) Ionic liquid-based ultrahigh pressure extraction of five tanshinones from Salvia miltiorrhiza Bunge. Sep Purif Technol 110:86\u201392","journal-title":"Sep Purif Technol"},{"key":"5664_CR84","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00262-019-02326-8","volume":"68","author":"S Liu","year":"2019","unstructured":"Liu S et al (2019) Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma. Cancer Immunol, Immunother\u202f: CII 68:1059\u20131071","journal-title":"Cancer Immunol, Immunother : CII"},{"key":"5664_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.149235","volume":"689","author":"W Liu","year":"2023","unstructured":"Liu W, Wang T, Wang W, Lin X, Xie K (2023) Tanshinone IIA promotes the proliferation and differentiation ability of primary muscle stem cells via MAPK and Akt signaling. Biochem Biophys Res Commun 689:149235","journal-title":"Biochem Biophys Res Commun"},{"key":"5664_CR86","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1007\/s00210-024-03166-9","volume":"397","author":"J Liu","year":"2024","unstructured":"Liu J et al (2024a) Tanshinol ameliorates imiquimod-induced psoriasis by inhibiting M1 macrophage polarization through suppression of the notch signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 397:8745\u20138758","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5664_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127923","volume":"254","author":"X-Q Liu","year":"2024","unstructured":"Liu X-Q et al (2024b) Tanshinone IIA, the key compound in Salvia miltiorrhiza, improves cognitive impairment by upregulating A\u03b2-degrading enzymes in APP\/PS1 mice. Int J Biol Macromol 254:127923","journal-title":"Int J Biol Macromol"},{"key":"5664_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106752","volume":"107","author":"C Luo","year":"2025","unstructured":"Luo C et al (2025) Development of tanshinone IIA chitosan nanoparticles via chitosan solid dispersion for improving the therapeutical effects. J Drug Deliv Sci Technol 107:106752","journal-title":"J Drug Deliv Sci Technol"},{"key":"5664_CR89","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41419-017-0247-5","volume":"9","author":"C Lv","year":"2018","unstructured":"Lv C et al (2018) The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG. Cell Death Dis 9:165","journal-title":"Cell Death Dis"},{"key":"5664_CR90","doi-asserted-by":"publisher","first-page":"16235","DOI":"10.3390\/molecules200916235","volume":"20","author":"X-H Ma","year":"2015","unstructured":"Ma X-H et al (2015a) The biosynthetic pathways of tanshinones and phenolic acids in Salvia miltiorrhiza. Molecules 20:16235\u201316254","journal-title":"Molecules"},{"key":"5664_CR91","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jep.2015.01.047","volume":"164","author":"Z Ma","year":"2015","unstructured":"Ma Z et al (2015b) Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor. J Ethnopharmacol 164:357\u2013367","journal-title":"J Ethnopharmacol"},{"key":"5664_CR92","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1142\/S0192415X22500781","volume":"50","author":"H Ma","year":"2022","unstructured":"Ma H et al (2022) Tanshinone IIA microemulsion protects against cerebral ischemia reperfusion injury via regulating H3K18ac and H4K8ac in vivo and in vitro. Am J Chin Med 50:1845\u20131868","journal-title":"Am J Chin Med"},{"key":"5664_CR93","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1007\/s11064-023-03985-x","volume":"48","author":"Z Ma","year":"2023","unstructured":"Ma Z et al (2023) Sodium tanshinone IIA sulfonate ameliorates oxygen-glucose deprivation\/reoxygenation-induced neuronal injury via protection of mitochondria and promotion of autophagy. Neurochem Res 48:3378\u20133390","journal-title":"Neurochem Res"},{"key":"5664_CR94","doi-asserted-by":"crossref","unstructured":"Ma Z et al. (2025) Tanshinone IIA alleviates tri-ortho-cresyl phosphate-induced ovarian damage through hippo signaling pathway activation in mice 18:85","DOI":"10.1186\/s13048-025-01671-w"},{"key":"5664_CR95","doi-asserted-by":"crossref","unstructured":"Maleki-Hajiagha A, Mojab F, Amidi F, Amini FLJBCM, therapies (2025) Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome\u2013a randomized placebo-controlled clinical trial 25:114","DOI":"10.1186\/s12906-025-04858-2"},{"key":"5664_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071572","author":"KR McSweeney","year":"2021","unstructured":"McSweeney KR et al (2021) Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13071572","journal-title":"Cancers (Basel)"},{"key":"5664_CR97","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1080\/13880209.2022.2070221","volume":"60","author":"Q Miao","year":"2022","unstructured":"Miao Q, Wang R, Sun X, Du S, Liu L (2022) Combination of puerarin and tanshinone IIA alleviates ischaemic stroke injury in rats via activating the Nrf2\/ARE signalling pathway. Pharm Biol 60:1022\u20131031","journal-title":"Pharm Biol"},{"key":"5664_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.155023","volume":"253","author":"OA Mohammed","year":"2024","unstructured":"Mohammed OA et al (2024) Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson\u2019s disease. Pathology-Res Prac 253:155023","journal-title":"Pathology-Res Prac"},{"key":"5664_CR99","doi-asserted-by":"publisher","unstructured":"Mustafa AM, El-Shiekh RA, Faheem SA et al (2025) Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol\u2019s potential for alopecia management. Futur J Pharm Sci 11:120. https:\/\/doi.org\/10.1186\/s43094-025-00878-4","DOI":"10.1186\/s43094-025-00878-4"},{"key":"5664_CR100","first-page":"245","volume":"48","author":"AH Neanaa","year":"2025","unstructured":"Neanaa AH, Arafa S, El-Heneidy M, Ashour AA, Nabil IM (2025) Effect of tanshinone IIA versus tanshinone IIA loaded nanocarriers on folic acid induced chronic toxicity of renal convoluted tubules in rats. Egypt J Histol 48:245\u2013265","journal-title":"Egypt J Histol"},{"key":"5664_CR101","doi-asserted-by":"publisher","first-page":"479","DOI":"10.4162\/nrp.2024.18.4.479","volume":"18","author":"J Ni","year":"2024","unstructured":"Ni J et al (2024) Cryptotanshinone promotes brown fat activity by AMPK activation to inhibit obesity. Nutr Res Pract 18:479\u2013497","journal-title":"Nutr Res Pract"},{"key":"5664_CR102","first-page":"3405","volume":"16","author":"J-M Nie","year":"2018","unstructured":"Nie J-M, Li H-F (2018) Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: a case-control study. Exp Ther Med 16:3405\u20133412","journal-title":"Exp Ther Med"},{"key":"5664_CR103","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0021-9673(01)00949-9","volume":"922","author":"X Pan","year":"2001","unstructured":"Pan X, Niu G, Liu H (2001) Microwave-assisted extraction of tanshinones from Salvia miltiorrhiza Bunge with analysis by high-performance liquid chromatography. J Chromatogr A 922:371\u2013375","journal-title":"J Chromatogr A"},{"key":"5664_CR104","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1369-703X(02)00039-6","volume":"12","author":"X Pan","year":"2002","unstructured":"Pan X, Niu G, Liu H (2002) Comparison of microwave-assisted extraction and conventional extraction techniques for the extraction of tanshinones from Salvia miltiorrhiza Bunge. Biochem Eng J 12:71\u201377","journal-title":"Biochem Eng J"},{"key":"5664_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.153171","author":"T Pan","year":"2025","unstructured":"Pan T, Zhu X, Sui Y, Zhang Z, Su Y (2025) Tanshinone IIA accelerates diabetic wound healing via suppression of macrophage NLRP3 inflammasome activity. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2025.153171","journal-title":"Biochem Biophys Res Commun"},{"key":"5664_CR106","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15188\/kjopp.2025.08.39.4.103","volume":"39","author":"GH Park","year":"2025","unstructured":"Park GH, Lee SH (2025) Dual role of tanshinone IIA on the differentiation and function of bone cells: regulation of Ca2+-oscillation in osteoclasts. J Physiol Pathol Korean Med 39:103\u2013112","journal-title":"J Physiol Pathol Korean Med"},{"key":"5664_CR107","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.fct.2009.08.007","volume":"47","author":"E-J Park","year":"2009","unstructured":"Park E-J, Zhao Y-Z, Kim Y-C, Sohn DH (2009) Preventive effects of a purified extract isolated from Salvia miltiorrhiza enriched with tanshinone I, tanshinone IIA and cryptotanshinone on hepatocyte injury in vitro and in vivo. Food Chem Toxicol 47:2742\u20132748","journal-title":"Food Chem Toxicol"},{"key":"5664_CR108","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1016\/j.bmc.2012.07.038","volume":"20","author":"J-Y Park","year":"2012","unstructured":"Park J-Y et al (2012) Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg Med Chem 20:5928\u20135935","journal-title":"Bioorg Med Chem"},{"key":"5664_CR109","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3390\/ijms18102065","volume":"18","author":"Y-K Park","year":"2017","unstructured":"Park Y-K et al (2017) Anti-adipogenic effects on 3T3-L1 cells and zebrafish by tanshinone IIA. Int J Mol Sci 18:2065","journal-title":"Int J Mol Sci"},{"key":"5664_CR110","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/JPER.24-0618","volume":"96","author":"ALR Pavanelli","year":"2025","unstructured":"Pavanelli ALR et al (2025) Anti-inflammatory and antiresorptive activities of tanshinone-IIA mitigate alveolar bone destruction in mice with experimental periodontitis. J Periodontol 96:1138\u20131153","journal-title":"J Periodontol"},{"key":"5664_CR111","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1039\/D5MD00637F","volume":"16","author":"G Polin\u00e1rio","year":"2025","unstructured":"Polin\u00e1rio G et al (2025) Tanshinones target drug-resistant tuberculosis: efficacy, selectivity, and potential mechanism of action. RSC Med Chem 16:6020\u20136030","journal-title":"RSC Med Chem"},{"key":"5664_CR112","doi-asserted-by":"crossref","unstructured":"Qin H et al. (2024) Tanshinone IIA ameliorates cisplatin-induced toxicology and cisplatin resistance via regulating SLC7A11 expression 39:1429\u20131441","DOI":"10.1002\/tox.24049"},{"key":"5664_CR113","doi-asserted-by":"crossref","unstructured":"Ren J, Fu L, Nile SH, Zhang J, Kai GJFIP (2019) Salvia miltiorrhiza in treating cardiovascular diseases: a review on its pharmacological and clinical applications 10:753","DOI":"10.3389\/fphar.2019.00753"},{"key":"5664_CR114","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1177\/09731296241246632","volume":"20","author":"W Ren","year":"2024","unstructured":"Ren W et al (2024) Effects of tanshinone IIA on cognitive impairment in Alzheimer\u2019s disease rats via oxidative stress, inflammatory responses and apoptosis. Pharmacogn Mag 20:1226\u20131236","journal-title":"Pharmacogn Mag"},{"key":"5664_CR115","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1021\/np010032f","volume":"64","author":"M Sairafianpour","year":"2001","unstructured":"Sairafianpour M et al (2001) Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1, 2-quinones from Perovskia abrotanoides: new source of tanshinones. J Nat Prod 64:1398\u20131403","journal-title":"J Nat Prod"},{"key":"5664_CR116","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.amjoto.2013.08.022","volume":"35","author":"L Shi","year":"2014","unstructured":"Shi L, An Y, Wang A, Gao Q, Yang Y (2014) The protective effect of Salvia miltiorrhiza on gentamicin-induced ototoxicity. Am J Otolaryngol 35:171\u2013179","journal-title":"Am J Otolaryngol"},{"key":"5664_CR117","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/0008-5472.CAN-08-2575","volume":"69","author":"DS Shin","year":"2009","unstructured":"Shin DS et al (2009) Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Res 69:193\u2013202","journal-title":"Cancer Res"},{"key":"5664_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.641848","volume":"12","author":"Z Song","year":"2021","unstructured":"Song Z et al (2021) Tanshinone IIA protects against cerebral ischemia reperfusion injury by regulating microglial activation and polarization via NF-\u03baB pathway. Front Pharmacol 12:641848","journal-title":"Front Pharmacol"},{"key":"5664_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.70086","volume":"41","author":"Q Su","year":"2025","unstructured":"Su Q, Chen J (2025) Regulatory effect and mechanism of tanshinone I on cell apoptosis in steroid\u2010induced osteonecrosis of the femoral head. Kaohsiung J Med Sci 41:e70086","journal-title":"Kaohsiung J Med Sci"},{"key":"5664_CR120","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2017.05.013","volume":"403","author":"H Sui","year":"2017","unstructured":"Sui H et al (2017) Tanshinone IIA inhibits \u03b2-catenin\/VEGF-mediated angiogenesis by targeting TGF-\u03b21 in normoxic and HIF-1\u03b1 in hypoxic microenvironments in human colorectal cancer. Cancer Lett 403:86\u201397","journal-title":"Cancer Lett"},{"key":"5664_CR121","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.jchromb.2011.05.014","volume":"879","author":"A Sun","year":"2011","unstructured":"Sun A, Zhang Y, Li A, Meng Z, Liu R (2011a) Extraction and preparative purification of tanshinones from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 879:1899\u20131904","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"5664_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-4","volume":"10","author":"D Sun","year":"2011","unstructured":"Sun D et al (2011b) Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3\u03b2 dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol 10:4","journal-title":"Cardiovasc Diabetol"},{"key":"5664_CR123","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1080\/10717544.2021.1931559","volume":"28","author":"G Sun","year":"2021","unstructured":"Sun G, Sun K, Sun J (2021) Combination prostate cancer therapy: prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone. Drug Deliv 28:1132\u20131140","journal-title":"Drug Deliv"},{"key":"5664_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121490","volume":"616","author":"J Sun","year":"2022","unstructured":"Sun J et al (2022) Hierarchically structured microcapsules for oral delivery of emodin and tanshinone IIA to treat renal fibrosis. Int J Pharm 616:121490","journal-title":"Int J Pharm"},{"key":"5664_CR125","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s13018-023-03934-y","volume":"18","author":"K Sun","year":"2023","unstructured":"Sun K et al (2023) Tanshinone I alleviates steroid-induced osteonecrosis of femoral heads and promotes angiogenesis: in vivo and in vitro studies. J Orthop Surg Res 18:474","journal-title":"J Orthop Surg Res"},{"key":"5664_CR126","doi-asserted-by":"publisher","first-page":"10418","DOI":"10.1007\/s12598-025-03605-3","volume":"44","author":"P-P Sun","year":"2025","unstructured":"Sun P-P et al (2025) Dihydrotanshinone I attenuates cisplatin-induced acute kidney injury by targeting TRIM28-mediated oxidative stress and apoptosis: insights from activity-based protein profiling and omics integration. Rare Met 44:10418\u201310428","journal-title":"Rare Met"},{"key":"5664_CR127","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jss.2015.02.062","volume":"197","author":"H Tang","year":"2015","unstructured":"Tang H et al (2015) Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-\u03b2-dependent epithelial to mesenchymal transition. J Surg Res 197:167\u2013175","journal-title":"J Surg Res"},{"key":"5664_CR128","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/exd.13511","volume":"27","author":"L Tang","year":"2018","unstructured":"Tang L et al (2018) Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT 3. Exp Dermatol 27:268\u2013275","journal-title":"Exp Dermatol"},{"key":"5664_CR129","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.redox.2013.10.004","volume":"1","author":"S Tao","year":"2013","unstructured":"Tao S, Justiniano R, Zhang DD, Wondrak GT (2013a) The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV. Redox Biol 1:532\u2013541","journal-title":"Redox Biol"},{"key":"5664_CR130","doi-asserted-by":"crossref","unstructured":"Tao S et al (2013b) Tanshinone I activates the Nrf2-dependent antioxidant response and protects against As (III)-induced lung inflammation in vitro and in vivo 19:1647\u20131661","DOI":"10.1089\/ars.2012.5117"},{"key":"5664_CR131","doi-asserted-by":"crossref","unstructured":"Tian W et al. (2026) Tanshinone IIA alleviates pyroptosis through SIRT1\/NLRP3 pathway to improve diabetic nephropathy. Am J Chinese Med 1\u201317","DOI":"10.1142\/S0192415X26500102"},{"key":"5664_CR132","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/ijmm.2022.5153","volume":"50","author":"D Tian","year":"2022","unstructured":"Tian D et al (2022) Tanshinone IIA protects against chronic obstructive pulmonary disease via exosome-shuttled miR-486-5p. Int J Mol Med 50:97","journal-title":"Int J Mol Med"},{"key":"5664_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119169","volume":"340","author":"W Tian","year":"2025","unstructured":"Tian W et al (2025) Tanshinone IIA, a component of Salvia miltiorrhiza Bunge, attenuated sepsis-induced liver injury via the SIRT1\/Sestrin2\/HO-1 signaling pathway. J Ethnopharmacol 340:119169","journal-title":"J Ethnopharmacol"},{"key":"5664_CR134","doi-asserted-by":"crossref","unstructured":"Wakabayashi N et al. (2010) When NRF2 talks, who\u2019s listening? 13:1649\u20131663","DOI":"10.1089\/ars.2010.3216"},{"key":"5664_CR135","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1128\/AAC.47.6.1836-1841.2003","volume":"47","author":"AM Wang","year":"2003","unstructured":"Wang AM, Sha SH, Lesniak W, Schacht J (2003) Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 47:1836\u20131841","journal-title":"Antimicrob Agents Chemother"},{"key":"5664_CR136","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1745-7254.2006.00357.x","volume":"27","author":"HG Wang","year":"2006","unstructured":"Wang HG, Li ZY, Liu XL (2006) Addition of tanshinone IIA to UW solution decreases skeletal muscle ischemia-reperfusion injury. Acta Pharmacol Sin 27:991\u2013999","journal-title":"Acta Pharmacol Sin"},{"key":"5664_CR137","doi-asserted-by":"crossref","unstructured":"Wang X, Morris\u2010Natschke SL, Lee KHJMRR (2007) New developments in the chemistry and biology of the bioactive constituents of Tanshen 27:133\u2013148","DOI":"10.1002\/med.20077"},{"key":"5664_CR138","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.lfs.2013.07.007","volume":"93","author":"L Wang","year":"2013","unstructured":"Wang L et al (2013) Dihydrotanshinone induces p53-independent but ROS-dependent apoptosis in colon cancer cells. Life Sci 93:344\u2013351","journal-title":"Life Sci"},{"key":"5664_CR139","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.intimp.2015.02.027","volume":"26","author":"D-T Wang","year":"2015","unstructured":"Wang D-T et al (2015a) Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-\u03b2\/Smad and NF-\u03baB signaling pathway in 5\/6 nephrectomized rats. Int Immunopharmacol 26:4\u201312","journal-title":"Int Immunopharmacol"},{"key":"5664_CR140","doi-asserted-by":"publisher","first-page":"17668","DOI":"10.3390\/ijms160817668","volume":"16","author":"D Wang","year":"2015","unstructured":"Wang D et al (2015b) Unveiling the mode of action of two antibacterial tanshinone derivatives. Int J Mol Sci 16:17668\u201317681","journal-title":"Int J Mol Sci"},{"key":"5664_CR141","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.phymed.2016.02.022","volume":"23","author":"W Wang","year":"2016","unstructured":"Wang W et al (2016) Tanshinone IIA protects against acetaminophen-induced hepatotoxicity via activating the Nrf2 pathway. Phytomedicine 23:589\u2013596","journal-title":"Phytomedicine"},{"key":"5664_CR142","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1039\/C8OB00567B","volume":"16","author":"F Wang","year":"2018","unstructured":"Wang F et al (2018) Total synthesis of (\u00b1)-tanshinol B, tanshinone I, and (\u00b1)-tanshindiol B and C. Org Biomol Chem 16:3376\u20133381","journal-title":"Org Biomol Chem"},{"key":"5664_CR143","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.taap.2019.05.014","volume":"376","author":"L Wang","year":"2019","unstructured":"Wang L, Cheng L, Zhang B, Wang N, Wang F (2019a) Tanshinone prevents alveolar bone loss in ovariectomized osteoporosis rats by up-regulating phosphoglycerate dehydrogenase. Toxicol Appl Pharmacol 376:9\u201316","journal-title":"Toxicol Appl Pharmacol"},{"key":"5664_CR144","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1111\/jcmm.14539","volume":"23","author":"W Wang","year":"2019","unstructured":"Wang W et al (2019b) Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK\/STAT3 signalling pathway. J Cell Mol Med 23:6454\u20136465","journal-title":"J Cell Mol Med"},{"key":"5664_CR145","first-page":"4189","volume":"12","author":"J Wang","year":"2020","unstructured":"Wang J et al (2020a) An injectable liposome for sustained release of tanshinone IIA to the treatment of acute blunt muscle injury by augmenting autophagy and alleviating oxidative stress. Am J Transl Res 12:4189","journal-title":"Am J Transl Res"},{"key":"5664_CR146","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.apha.2019.10.001","volume":"87","author":"X Wang","year":"2020","unstructured":"Wang X, Yang Y, Liu X, Gao X (2020b) Pharmacological properties of tanshinones, the natural products from Salvia miltiorrhiza. Adv Pharmacol 87:43\u201370","journal-title":"Adv Pharmacol"},{"key":"5664_CR147","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1080\/10717544.2022.2072543","volume":"29","author":"J Wang","year":"2022","unstructured":"Wang J et al (2022a) Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer\u2019s disease. Drug Deliv 29:1648\u20131662","journal-title":"Drug Deliv"},{"key":"5664_CR148","first-page":"414","volume":"25","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022b) Protective effects of tanshinone \u2160 against cisplatin-induced nephrotoxicity in mice. Iran J Basic Med Sci 25:414\u2013418","journal-title":"Iran J Basic Med Sci"},{"key":"5664_CR149","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2025.4218","volume":"69","author":"D Wang","year":"2025","unstructured":"Wang D, Tan Q, Zheng Q, Ma Y, Feng L (2025a) Tanshinone IIA attenuates hepatic stellate cell activation, oxidative stress, and liver fibrosis by inhibiting YAP signaling. Eur J Histochem 69:4218","journal-title":"Eur J Histochem"},{"key":"5664_CR150","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2147\/DDDT.S504485","volume":"19","author":"Q Wang","year":"2025","unstructured":"Wang Q et al (2025b) Tanshinone I ameliorates psoriasis-like dermatitis by suppressing inflammation and regulating keratinocyte differentiation. Drug des Devel Ther 19:539\u2013552","journal-title":"Drug des Devel Ther"},{"key":"5664_CR151","doi-asserted-by":"publisher","DOI":"10.2174\/18755666MTA53OTMcx","author":"TU Wani","year":"2021","unstructured":"Wani TU (2021) Exosomes harnessed as nanocarriers for cancer therapy - current status and potential for future clinical applications. Curr Mol Med. https:\/\/doi.org\/10.2174\/18755666MTA53OTMcx","journal-title":"Curr Mol Med"},{"key":"5664_CR152","doi-asserted-by":"crossref","unstructured":"Wei W et al. (2024) Sodium tanshinone IIA sulfonate alleviates vascular senescence in diabetic mice by modulating the A20-NF\u03baB-NLRP3 inflammasome-catalase pathway 14:17665","DOI":"10.1038\/s41598-024-68169-1"},{"key":"5664_CR153","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.biopha.2017.06.040","volume":"93","author":"Y Wei","year":"2017","unstructured":"Wei Y et al (2017) Tanshinone I alleviates insulin resistance in type 2 diabetes mellitus rats through IRS-1 pathway. Biomed Pharmacother 93:352\u2013358","journal-title":"Biomed Pharmacother"},{"key":"5664_CR154","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1002\/jssc.200900398","volume":"32","author":"K Wu","year":"2009","unstructured":"Wu K et al (2009) Ionic liquid surfactant-mediated ultrasonic-assisted extraction coupled to HPLC: application to analysis of tanshinones in Salvia miltiorrhiza Bunge. J Sep Sci 32:4220\u20134226","journal-title":"J Sep Sci"},{"key":"5664_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094957","volume":"9","author":"W-Y Wu","year":"2014","unstructured":"Wu W-Y et al (2014) Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase. PLoS ONE 9:e94957","journal-title":"PLoS ONE"},{"key":"5664_CR156","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1021\/acs.jnatprod.7b00238","volume":"80","author":"N Wu","year":"2017","unstructured":"Wu N, Ma W-C, Mao S-J, Wu Y, Jin H (2017) Total synthesis of tanshinone I. J Nat Prod 80:1697\u20131700","journal-title":"J Nat Prod"},{"key":"5664_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.644116","volume":"12","author":"Y-T Wu","year":"2021","unstructured":"Wu Y-T et al (2021) Tanshinone I inhibits oxidative stress\u2013induced cardiomyocyte injury by modulating Nrf2 signaling. Front Pharmacol 12:644116","journal-title":"Front Pharmacol"},{"key":"5664_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-022-03592-3","volume":"22","author":"M Wu","year":"2022","unstructured":"Wu M, Yang F, Huang D, Ye C (2022) Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A. BMC Complement Med Ther 22:110","journal-title":"BMC Complement Med Ther"},{"key":"5664_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116667","volume":"316","author":"Q Wu","year":"2023","unstructured":"Wu Q, Guan Y-B, Zhang K-J, Li L, Zhou Y (2023) Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis. J Ethnopharmacol 316:116667","journal-title":"J Ethnopharmacol"},{"key":"5664_CR160","doi-asserted-by":"crossref","unstructured":"Xu M et al (2011) Tanshinone IIA\u2013induced attenuation of lung injury in endotoxemic mice is associated with reduction of hypoxia-inducible factor 1\u03b1 expression 45:1028\u20131035","DOI":"10.1165\/rcmb.2011-0113OC"},{"key":"5664_CR161","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s257734","author":"S Xu","year":"2020","unstructured":"Xu S et al (2020) Tanshinone IIA ameliorates streptozotocin-induced diabetic nephropathy, partly by attenuating PERK pathway-induced fibrosis. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/dddt.s257734","journal-title":"Drug Des Devel Ther"},{"key":"5664_CR162","doi-asserted-by":"crossref","unstructured":"Xu M et al. (2015) Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice 36:179\u2013187","DOI":"10.1038\/aps.2014.112"},{"key":"5664_CR163","unstructured":"Xu K, Cheng WT, Hu ZW, Wang S (2016) [Effect of tanshinone IIA in preventing and treating oxaliplatin induced peripheral neuropathy]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese J Integr Tradit Western Med 36:559\u2013563"},{"key":"5664_CR164","doi-asserted-by":"publisher","first-page":"8002161","DOI":"10.1155\/2021\/8002161","volume":"2021","author":"X Xu","year":"2021","unstructured":"Xu X et al (2021) Tanshinone I mitigates steroid-induced osteonecrosis of the femoral head and activates the Nrf2 signaling pathway in rats. Evidence-Based Complement Altern Med 2021:8002161","journal-title":"Evidence-Based Complement Altern Med"},{"key":"5664_CR165","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3892\/etm.2022.11413","volume":"24","author":"L Xu","year":"2022","unstructured":"Xu L et al (2022) Tanshinone IIA regulates the TGF-\u03b21\/Smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis. Exp Ther Med 24:486","journal-title":"Exp Ther Med"},{"key":"5664_CR166","doi-asserted-by":"crossref","unstructured":"Xu H et al. (2024) Diterpenoid tanshinones can inhibit lung cancer progression by improving the tumor microenvironment and downregulation of NF-\u039ab expression 9:7230\u20137238","DOI":"10.1021\/acsomega.3c09667"},{"key":"5664_CR167","first-page":"855","volume":"29","author":"MY Yan","year":"2012","unstructured":"Yan MY, Chien SY, Kuo SJ, Chen DR, Su CC (2012) Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression. Int J Mol Med 29:855\u2013863","journal-title":"Int J Mol Med"},{"key":"5664_CR168","doi-asserted-by":"crossref","unstructured":"Yang G et al (2020) Protective effect of tanshinone IIA on H2O2-induced oxidative stress injury in rat cardiomyocytes by activating Nrf2 pathway 40:264\u2013272","DOI":"10.1080\/10799893.2020.1731535"},{"key":"5664_CR169","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/15384101.2022.2129933","volume":"22","author":"N Yang","year":"2023","unstructured":"Yang N et al (2023a) Tanshinone increases hemopexin expression in lung cells and macrophages to protect against cigarette smoke-induced COPD and enhance antiviral responses. Cell Cycle 22:645\u2013665","journal-title":"Cell Cycle"},{"key":"5664_CR170","doi-asserted-by":"crossref","unstructured":"Yang N et al. (2023b) Tanshinone increases hemopexin expression in lung cells and macrophages to protect against cigarette smoke-induced COPD and enhance antiviral responses 22:645\u2013665","DOI":"10.1080\/15384101.2022.2129933"},{"key":"5664_CR171","doi-asserted-by":"publisher","first-page":"563","DOI":"10.5498\/wjp.v14.i4.563","volume":"14","author":"L-X Yang","year":"2024","unstructured":"Yang L-X, Luo M, Li S-Y (2024) Tanshinone IIA improves Alzheimer\u2019s disease via RNA nuclear-enriched abundant transcript 1\/microRNA-291a-3p\/member RAS oncogene family Rab22a axis. World J Psychiatry 14:563","journal-title":"World J Psychiatry"},{"key":"5664_CR172","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12272-001-1209-2","volume":"31","author":"H-Q Yin","year":"2008","unstructured":"Yin H-Q et al (2008) Effects of tanshinone IIA on the hepatotoxicity and gene expression involved in alcoholic liver disease. Arch Pharm Res 31:659\u2013665","journal-title":"Arch Pharm Res"},{"key":"5664_CR173","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3892\/or.2017.5408","volume":"37","author":"J Yu","year":"2017","unstructured":"Yu J, Wang X, Li Y, Tang B (2017) Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1. Oncol Rep 37:1394\u20131400","journal-title":"Oncol Rep"},{"key":"5664_CR174","doi-asserted-by":"crossref","unstructured":"Yu Y et al. (2025) Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review 16:1624569","DOI":"10.3389\/fphar.2025.1624569"},{"key":"5664_CR175","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9990937","author":"X Zeng","year":"2022","unstructured":"Zeng X et al (2022) Study on the antioxidant effect of tanshinone IIA on diabetic retinopathy and its mechanism based on integrated pharmacology. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2022\/9990937","journal-title":"Evid Based Complement Alternat Med"},{"key":"5664_CR176","doi-asserted-by":"crossref","unstructured":"Zhang Y et al (2012) Tanshinones: sources, pharmacokinetics and anti-cancer activities 13:13621\u201313666","DOI":"10.3390\/ijms131013621"},{"key":"5664_CR177","doi-asserted-by":"crossref","unstructured":"Zhang X et al (2023a) Tanshinone \u2161A participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K\/Akt\/mTOR signaling pathway 28:221","DOI":"10.3892\/mmr.2023.13108"},{"key":"5664_CR178","doi-asserted-by":"crossref","unstructured":"Zhang M et al (2024a) The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs 10","DOI":"10.1016\/j.heliyon.2024.e37326"},{"key":"5664_CR179","doi-asserted-by":"crossref","unstructured":"Zhang YZ et al (2024b) Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer. Phytomedicine: Int J Phytother Phytopharmacol 128:155431","DOI":"10.1016\/j.phymed.2024.155431"},{"key":"5664_CR180","doi-asserted-by":"crossref","unstructured":"Zhang W et al (2025a) Tanshinone IIA regulates NRF2\/NLRP3 signal pathway to restrain oxidative stress and inflammation in uric acid-induced HK-2 fibrotic models 25:721\u2013731","DOI":"10.2174\/0118715303315786240926075342"},{"key":"5664_CR181","unstructured":"Zhang Wl, Liu JP, Liu XX, Chen ZQ (2009) Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats. Yao xue xue bao= Acta Pharmaceutica Sinica 44:1421\u20131428"},{"key":"5664_CR182","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijpharm.2010.03.011","volume":"391","author":"W-L Zhang","year":"2010","unstructured":"Zhang W-L et al (2010) Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug. Int J Pharm 391:313\u2013321","journal-title":"Int J Pharm"},{"key":"5664_CR183","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/jcp.24552","volume":"229","author":"HS Zhang","year":"2014","unstructured":"Zhang HS, Chen XY, Wu TC, Zhang FJ (2014) Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK\/Nampt pathway. J Cell Physiol 229:1193\u20131201","journal-title":"J Cell Physiol"},{"key":"5664_CR184","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S165590","author":"S Zhang","year":"2018","unstructured":"Zhang S, Li J, Hu S, Wu F, Zhang X (2018) Triphenylphosphonium and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S165590","journal-title":"Int J Nanomedicine"},{"key":"5664_CR185","first-page":"6554","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang L et al (2019) Tanshinone IIA reverses EGF- and TGF-\u03b21-mediated epithelial-mesenchymal transition in HepG2 cells via the PI3K\/Akt\/ERK signaling pathway. Oncol Lett 18:6554\u20136562","journal-title":"Oncol Lett"},{"key":"5664_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110547","volume":"130","author":"X Zhang","year":"2020","unstructured":"Zhang X et al (2020) Tanshinone IIA attenuates acetaminophen-induced hepatotoxicity through HOTAIR-Nrf2-MRP2\/4 signaling pathway. Biomed Pharmacother 130:110547","journal-title":"Biomed Pharmacother"},{"key":"5664_CR187","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/tox.23511","volume":"37","author":"X Zhang","year":"2022","unstructured":"Zhang X et al (2022) Tanshinone IIA prevents acetaminophen-induced nephrotoxicity through the activation of the Nrf2-Mrp2\/4 pathway in mice. Environ Toxicol 37:1618\u20131628","journal-title":"Environ Toxicol"},{"key":"5664_CR188","doi-asserted-by":"publisher","first-page":"20228156","DOI":"10.1515\/gps-2022-8156","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X et al (2023b) Nano-encapsulated tanshinone IIA in PLGA-PEG-COOH inhibits apoptosis and inflammation in cerebral ischemia\/reperfusion injury. Green Process Synth 12:20228156","journal-title":"Green Process Synth"},{"key":"5664_CR189","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.reth.2025.08.004","volume":"30","author":"Y Zhang","year":"2025","unstructured":"Zhang Y et al (2025b) Tanshinone IIA suppresses fibro-adipogenic progenitor differentiation and attenuates fat infiltration in rotator cuff injury via Wnt\/\u03b2-catenin pathway. Regen Ther 30:584\u2013594","journal-title":"Regen Ther"},{"key":"5664_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117635","volume":"245","author":"QY Zhang","year":"2026","unstructured":"Zhang QY et al (2026) Renin inhibition improved muscular function by alleviating insulin resistance and AGEs\/RAGE signaling in skeletal muscle associated with high glucose: exploration of renin inhibitor tanshinone IIA. Biochem Pharmacol 245:117635","journal-title":"Biochem Pharmacol"},{"key":"5664_CR191","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3390\/molecules16032259","volume":"16","author":"J Zhao","year":"2011","unstructured":"Zhao J et al (2011) Diterpenoid tanshinones and phenolic acids from cultured hairy roots of Salvia miltiorrhiza Bunge and their antimicrobial activities. Molecules 16:2259\u20132267","journal-title":"Molecules"},{"key":"5664_CR192","volume":"16","author":"L Zhao","year":"2021","unstructured":"Zhao L et al (2021) Antibacterial mechanism of dihydrotanshinone I. Nat Prod Commun 16:1934578X21996158","journal-title":"Nat Prod Commun"},{"key":"5664_CR193","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s10020-023-00671-0","volume":"29","author":"J Zhao","year":"2023","unstructured":"Zhao J et al (2023) Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC. Mol Med 29:84","journal-title":"Mol Med"},{"key":"5664_CR194","doi-asserted-by":"crossref","unstructured":"Zhao Z et al (2026) Natural products modulate programmed cell death signaling mechanism for treating endometriosis: a review 17:1742212","DOI":"10.3389\/fphar.2026.1742212"},{"key":"5664_CR195","doi-asserted-by":"publisher","DOI":"10.4268\/cjcmm20161718","author":"J Zheng","year":"2016","unstructured":"Zheng J et al (2016) Preparation of tanshinone \u2161A loaded nanostructured lipid carrier and its in vitro transdermal permeation characteristics. Zhongguo Zhong Yao Za Zhi. https:\/\/doi.org\/10.4268\/cjcmm20161718","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"1","key":"5664_CR196","doi-asserted-by":"publisher","first-page":"21726","DOI":"10.1038\/s41598-021-01121-9","volume":"11","author":"J Zhong","year":"2021","unstructured":"Zhong J, Wang H, Zhuang Y, Shen Q (2021) Identification of the antibacterial mechanism of cryptotanshinone on methicillin-resistant Staphylococcus aureus using bioinformatics analysis. Sci Rep 11:21726","journal-title":"Sci Rep"},{"key":"5664_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10215-2","volume":"7","author":"W Zhou","year":"2017","unstructured":"Zhou W et al (2017) Comprehensive transcriptome profiling of Salvia miltiorrhiza for discovery of genes associated with the biosynthesis of tanshinones and phenolic acids. Sci Rep 7:10554","journal-title":"Sci Rep"},{"key":"5664_CR198","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jphp.12650","volume":"69","author":"J Zhu","year":"2017","unstructured":"Zhu J, Liao S, Zhou L, Wan L (2017) Tanshinone IIA attenuates A\u03b225\u201335-induced spatial memory impairment via upregulating receptors for activated C kinase1 and inhibiting autophagy in hippocampus. J Pharm Pharmacol 69:191\u2013201","journal-title":"J Pharm Pharmacol"},{"key":"5664_CR199","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1165212","volume":"14","author":"P-C Zhu","year":"2023","unstructured":"Zhu P-C et al (2023) Effect of tanshinone IIA for myocardial ischemia\/reperfusion injury in animal model: preclinical evidence and possible mechanisms. Front Pharmacol 14:1165212","journal-title":"Front Pharmacol"},{"issue":"4","key":"5664_CR200","doi-asserted-by":"publisher","first-page":"uhae047","DOI":"10.1093\/hr\/uhae047","volume":"11","author":"B Zhu","year":"2024","unstructured":"Zhu B et al (2024) The Smi-miR858a-SmMYB module regulates tanshinone and phenolic acid biosynthesis in Salvia miltiorrhiza. Hortic Res 11:uhae047","journal-title":"Hortic Res"},{"key":"5664_CR201","doi-asserted-by":"crossref","unstructured":"Zou C et al (2023) Tanshinone IIA mediates the apoptosis and proliferation of endometrial cancer through the CK2\/DBC1\/SIRT1\/P53 pathway","DOI":"10.21203\/rs.3.rs-3649577\/v1"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05664-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:02:38Z","timestamp":1792882958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05664-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":201,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5664"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05664-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}